TNF and rheumatoid arthritis: Biological agents such as anti-tumor necrosis factor (TNF)-α antibodies have demonstrated efficacy in treating RA; however, their clinical use carries the risk of infusion and injection site infections, and their efficacy may vary depending on the patient’s individual needs (Zhao et al., 2022a).